Drug Profile


Alternative Names: ACP-HIP; hCG - Altachem; Human chorionic gonadotropin - Altachem

Latest Information Update: 16 Oct 2007

Price : $50

At a glance

  • Originator University of Montreal
  • Class Antineoplastics; Hormones
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • Phase I HIV infections
  • Suspended Kaposi's sarcoma
  • Discontinued Cancer

Most Recent Events

  • 16 Oct 2007 Discontinued - Preclinical for Cancer in China (unspecified route)
  • 16 Oct 2007 This programme appears to be in active development
  • 07 Feb 2006 Dr Tony Antakly (University of Montreal) has reacquired ACP HIP from Quest PharmaTech
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top